| Literature DB >> 26838993 |
Caroline Lamarche1, Maude Pichette1, Denis Ouimet1, Michel Vallée1, Robert Bell1, Georges Ouellet1, John Stewart2, Vincent Pichette3.
Abstract
The aim of our study was to evaluate the efficacy and bioavailibility of a commonly used oral furosemide dose (500 mg) compared to a 250 mg intravenous (IV) dose in PD patients with significant residual renal function (urine volume > 100 mL). We also evaluated the immediate blood pressure effect in these patients. The data were obtained from a study we performed for the homologation of a 500-mg dose of furosemide by Health Canada.Entities:
Keywords: Furosemide; blood pressure; diuresis; natriuresis; pharmacodynamic; pharmacokinetic
Mesh：
Substances：
Year: 2016 PMID： 26838993 PMCID： PMC4737575 DOI： 10.3747/pdi.2014.00328
Source DB: PubMed Journal: Perit Dial Int ISSN： 0896-8608 Impact factor: 1.756